Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Centre,Randomized,Phase IV Study to Assess the Topical r-Hirudin (Thrombexx)Efficacy in the Patients With Haematomas

NCT01960569 is registered in ClinicalTrials.gov with MinaPharm Pharmaceuticals as lead sponsor.

NCT NCT01960569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01960569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Centre,Randomized,Phase IV Study to Assess the Topical r-Hirudin (Thrombexx)Efficacy in the Patients With Haematomas
Lead sponsor
MinaPharm Pharmaceuticals
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2013
Completion date
April 30, 2014
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

r-hirudin (thrombexx) efficacy in treatment of haematomas